Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MDT | Medtronic PLC | 1.12% | 85.09 | 0.6% | $483.04m | |
| ISRG | Intuitive Surgical, Inc. | 1.91% | 500.42 | 2.4% | $427.40m | |
| TMO | Thermo Fisher Scientific Inc. | 1.77% | 263.67 | 1.0% | $423.24m | |
| ABT | Abbott Laboratories | 2.13% | 76.10 | 0.8% | $406.97m | |
| BDX | Becton, Dickinson and Company | 1.31% | 227.99 | 1.1% | $340.92m | |
| ALGN | Align Technology, Inc. | 1.88% | 296.08 | 6.3% | $305.74m | |
| BSX | Boston Scientific Corporation | 2.72% | 35.88 | 1.1% | $297.08m | |
| SYK | Stryker Corporation | 2.60% | 186.90 | 1.3% | $254.28m | |
| BAX | Baxter International Inc. | 1.44% | 76.33 | 1.7% | $228.48m | |
| ABMD | ABIOMED, Inc. | 0.48% | 262.18 | 3.3% | $223.46m | |
| EW | Edwards Lifesciences Corporation | 1.51% | 180.96 | 1.2% | $211.43m | |
| DXCM | DexCom, Inc. | 1.22% | 118.03 | 8.5% | $161.88m | |
| ZBH | Zimmer Biomet Holdings, Inc. | 1.27% | 122.74 | 1.7% | $139.47m | |
| WAT | Waters Corporation | -12.34% | 211.30 | 3.5% | $129.03m | |
| TNDM | Tandem Diabetes Care, Inc. | 3.21% | 58.58 | 4.1% | $105.80m |
Company Profile
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. The DNAG segment manufactures and sells specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.